In this episode of the Oncology Brothers podcast, we welcomed Dr. Jonathan Friedberg, a leading lymphoma expert, to discuss modern treatment approaches for follicular lymphoma and mantle cell lymphoma.
Join us as we explored:
The diagnostic workup for follicular lymphoma, including the role of bone marrow biopsy and staging imaging
Treatment strategies for early-stage and symptomatic follicular lymphoma, including rituximab, obinutuzumab, and chemotherapy-based approaches
The evolving role of maintenance therapy and what recent studies have shown about progression-free and overall survival
New treatment options in relapsed/refractory follicular lymphoma, including tafasitamab and epcoritamab
The importance of TP53 testing in mantle cell lymphoma and the evolving role of BTK inhibitors in frontline treatment
The role of CAR T-cell therapy and bispecific antibodies in the evolving lymphoma treatment landscape
This discussion provided practical insights into current treatment algorithms and emerging strategies for patients with follicular lymphoma and mantle cell lymphoma.
Whether you're a hematologist, oncologist, advanced practice provider, nurse, pharmacist, trainee, or healthcare professional interested in lymphoma care, this episode offers an expert perspective on the rapidly evolving treatment landscape.
If you found this discussion valuable, please like the video, subscribe to the Oncology Brothers, and share your thoughts in the comments.
Subscribe for more expert discussions on hematology, oncology, lymphoma, immunotherapy, cellular therapy, targeted therapy, and advances in cancer care.
Podden och tillhörande omslagsbild på den här sidan tillhör
Oncology Brothers. Innehållet i podden är skapat av Oncology Brothers och inte av,
eller tillsammans med, Poddtoppen.
